Novartis Venture Fund
Baselnvfund.com
Overview
Novartis Venture Fund is a corporate venture capital firm that invests in a wide array of companies working in biotechnology and biopharmaceuticals at various stages of growth and development across North America and Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sidewinder | Apr 2026 | Series B | Lead |
| Sidewinder Therapeutics | Apr 2026 | Series B | Lead |
| EpiBiologics | Jan 2026 | Series B | Co-investor |
| FoRx Therapeutics | Dec 2025 | Series A | Co-investor |
| Protego Biopharma | Dec 2025 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
